Similar Papers

Paper Title
Journal
Date
Author
Randomized phase II trial of single agent erlotinib vs. standard chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2
R Lilenbaum ... R Axerold
Journal of Clinical Oncology | VOL. 24
R Lilenbaum, et. al.R Lilenbaum ... R Axerold
20 Jun 2006
Abstract C122: A randomized, multicenter, open-label, phase 2 study of paclitaxel-carboplatin (PC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus PC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC)
David Spigel ... Mazen Khalil
Molecular Cancer Therapeutics | VOL. 14
David Spigel, et. al.David Spigel ... Mazen Khalil
01 Dec 2015
Dostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
...
Journal of Clinical Oncology | VOL. 41
, et. al. ...
01 Jun 2023
A randomized phase II study assessing an optimized schedule of oregovomab (O) anti-CA125 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC).
Gabriella Ferrandina ... Christopher F Nicodemus
Journal of Clinical Oncology | VOL. 35
Gabriella Ferrandina, et. al.Gabriella Ferrandina ... Christopher F Nicodemus
20 May 2017
View more papers

More From: International Journal of Radiation Oncology*Biology*Physics

Paper Title
Journal
Date
Author
Concurrent and consolidative carboplatin plus nab-paclitaxel or paclitaxel in locally advanced NSCLC A multicenter, randomized clinical trial
Yuanyuan Zhang ... David E Gerber
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Yuanyuan Zhang, et. al.Yuanyuan Zhang ... David E Gerber
01 Feb 2025
Patterns of relapse following radiotherapy of intermediate-risk (IR) prostate cancer (PCa) on the PROFIT randomized trial
M Langé ... S Supiot
International Journal of Radiation Oncology*Biology*Physics | VOL. -
M Langé, et. al.M Langé ... S Supiot
01 Feb 2025
Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580.
Vinai Gondi ... Lisa A Kachnic
International Journal of Radiation Oncology*Biology*Physics | VOL. 121
Vinai Gondi, et. al.Vinai Gondi ... Lisa A Kachnic
01 Feb 2025
A Dual Energy CT-Guided Intelligent Radiation Therapy Platform
Ning Wen ... Jiayi Chen
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Ning Wen, et. al.Ning Wen ... Jiayi Chen
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.